Christophe Biot Selected Research

ferroquine

11/2017	Ferroquine, the next generation antimalarial drug, has antitumor activity.
1/2014	Ferroquine as an oxidative shock antimalarial.
7/2013	The ferroquine antimalarial conundrum: redox activation and reinvasion inhibition.
6/2012	Pharmacokinetics of ferroquine, a novel 4-aminoquinoline, in asymptomatic carriers of Plasmodium falciparum infections.
11/2010	Synthesis and antimalarial activities of rhenium bioorganometallics based on the 4-aminoquinoline structure.
7/2006	Probing the role of the covalent linkage of ferrocene into a chloroquine template.
4/2006	In vitro metabolism of ferroquine (SSR97193) in animal and human hepatic models and antimalarial activity of major metabolites on Plasmodium falciparum.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Christophe Biot Research Topics

Disease

11	Malaria 07/2013 - 05/2005
4	Infections 01/2020 - 05/2006
4	Neoplasms (Cancer) 11/2017 - 12/2011
3	Tuberculosis (Tuberculoses) 01/2020 - 05/2011
2	Pathologic Processes 01/2017 - 12/2013
2	Shock 09/2014 - 01/2014
2	Breast Neoplasms (Breast Cancer) 08/2012 - 12/2011
1	Sialic Acid Storage Disease (Salla Disease) 01/2020
1	Gerodermia osteodysplastica 10/2019
1	Hypoxia (Hypoxemia) 11/2017
1	Cystic Fibrosis (Mucoviscidosis) 01/2016
1	Toxoplasmosis 01/2015
1	Neglected Diseases 09/2014
1	Schistosomiasis (Bilharziasis) 09/2014
1	Congenital Disorders of Glycosylation 12/2013
1	Sleep Initiation and Maintenance Disorders (Insomnia) 05/2013
1	Pain (Aches) 05/2013
1	Spasm (Spasms) 05/2013
1	Nausea 05/2013
1	Edema (Dropsy) 05/2010
1	Glioblastoma (Glioblastoma Multiforme) 04/2010

Drug/Important Bio-Agent (IBA)

7	ferroquineIBA 11/2017 - 04/2006
6	Pharmaceutical PreparationsIBA 11/2019 - 04/2010
6	Antimalarials (Antimalarial Agents)IBA 11/2017 - 06/2006
4	Chloroquine (Aralen)FDA LinkGeneric 09/2014 - 05/2005
2	Polysaccharides (Glycans)IBA 01/2017 - 12/2013
2	N-Acetylneuraminic Acid (Sialic Acid)IBA 01/2017 - 12/2013
2	LigandsIBA 07/2013 - 12/2011
2	alpha-L-Fucosidase (Fucosidase)IBA 07/2013 - 08/2012
1	Mycolic Acids (Mycolic Acid)IBA 01/2020
1	sialic acid transport proteinsIBA 01/2020
1	trehalose monomycolateIBA 11/2019
1	Proteins (Proteins, Gene)FDA Link 10/2019
1	Coat Protein Complex I (COPI)IBA 10/2019
1	Phosphotransferases (Kinase)IBA 11/2017
1	CaspasesIBA 11/2017
1	Anti-Bacterial Agents (Antibiotics)IBA 01/2016
1	Ciprofloxacin (Cipro)FDA LinkGeneric 01/2015
1	Coordination ComplexesIBA 09/2014
1	MonosaccharidesIBA 12/2013
1	FucoseIBA 07/2013
1	Psychotropic Drugs (Psychoactive Drugs)IBA 05/2013
1	ferroceneIBA 08/2012
1	4-aminoquinolineIBA 06/2012
1	Cisplatin (Platino)FDA LinkGeneric 12/2011
1	Hydrocortisone (Cortisol)FDA LinkGeneric 05/2010
1	Doxorubicin (Adriamycin)FDA LinkGeneric 05/2010
1	Prednisolone (Predate)FDA LinkGeneric 05/2010
1	falcipain 2IBA 12/2007
1	Cysteine Proteases (Cysteine Protease)IBA 12/2007
1	Biological ProductsIBA 12/2007
1	Antiviral Agents (Antivirals)IBA 05/2006

Therapy/Procedure

2	Therapeutics 11/2017 - 11/2010
1	Drug Therapy (Chemotherapy) 01/2020